Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Telemonitoring to Treat Group 2 Pulmonary Hypertension: A Personalized Approach

NCT04882774 is registered in ClinicalTrials.gov with Mardi Gomberg -Maitland MD, MSc as lead sponsor.

NCT NCT04882774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04882774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Telemonitoring to Treat Group 2 Pulmonary Hypertension: A Personalized Approach
Lead sponsor
Mardi Gomberg -Maitland MD, MSc
Phase
Phase 2
Overall status
Withdrawn
Start date
April 30, 2023
Completion date
April 30, 2027
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension due to left heart disease